A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer.
Peter Schlegel
Index: BJU Int. 103 Suppl 2 , 7-13, (2009)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
2015-10-12
[Eur. J. Pharm. Sci. 78 , 31-6, (2015)]
2015-03-02
[Mol. Pharm. 12(3) , 966-73, (2015)]
2013-06-01
[J. Clin. Endocrinol. Metab. 98(6) , 2198-207, (2013)]
2014-09-01
[PLoS Biol. 12(9) , e1001952, (2014)]
2014-04-01
[J. Pediatr. 164(4) , 912-916.e1, (2014)]